Vivani Medical, Inc. (NASDAQ:VANI) Director Buys $4,999,998.78 in Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 3,968,253 shares of the company's stock in a transaction dated Friday, November 8th. The shares were bought at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the purchase, the director now owns 4,695,861 shares of the company's stock, valued at approximately $5,916,784.86. This trade represents a 500.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Vivani Medical Stock Up 11.2 %

Shares of Vivani Medical stock opened at $1.39 on Thursday. The business has a 50 day moving average of $1.22 and a 200 day moving average of $1.36. Vivani Medical, Inc. has a 52 week low of $0.84 and a 52 week high of $7.80. The company has a market cap of $76.81 million, a PE ratio of -2.96 and a beta of 3.20.

Vivani Medical (NASDAQ:VANI - Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.10) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.02.

Analysts Set New Price Targets


“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
>> YES! Send Me My FREE Gold Guide!


Separately, HC Wainwright initiated coverage on Vivani Medical in a report on Thursday, November 7th. They set a "buy" rating and a $3.00 price target on the stock.

Check Out Our Latest Research Report on VANI

About Vivani Medical

(Get Free Report)

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.

Recommended Stories

Insider Buying and Selling by Quarter for Vivani Medical (NASDAQ:VANI)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Vivani Medical?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Vivani Medical and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles